Available via license: CC BY 4.0
Content may be subject to copyright.
applied
sciences
Review
Fluoride and Pineal Gland
Dariusz Chlubek 1, * and Maciej Sikora 1,2
1Department of Biochemistry and Medical Chemistry, Pomeranian Medical University,
Powsta´nców Wlkp. 72, 70-111 Szczecin, Poland; sikora-maciej@wp.pl
2Department of Maxillofacial Surgery, Hospital of the Ministry of Interior, Wojska Polskiego 51,
25-375 Kielce, Poland
*Correspondence: dchlubek@pum.edu.pl
Received: 28 March 2020; Accepted: 20 April 2020; Published: 22 April 2020
Abstract:
The pineal gland is an endocrine gland whose main function is the biosynthesis and secretion
of melatonin, a hormone responsible for regulating circadian rhythms, e.g.,
the sleep/wake cycle
.
Due to its exceptionally high vascularization and its location outside the blood–brain barrier,
the pineal
gland may accumulate significant amounts of calcium and fluoride, making it the most
fluoride-saturated organ of the human body. Both the calcification and accumulation of fluoride may
result in melatonin deficiency.
Keywords: fluoride; pineal gland; calcification of soft tissues; melatonin
1. Introduction
The effect of fluoride on the human body is characterized by a very narrow margin of safety,
which means
that even relatively low concentrations may cause various adverse or even toxic
effects
[1–5]
. The risk naturally increases with the intensity and duration of the exposure,
with long-term
exposure resulting in chronic poisoning [
6
,
7
]. One of the defense mechanisms protecting the body
against the effects of fluoride toxicity seems to be its deposition in calcified tissues [
2
]. The most
important role is played by hard tissues; bones; and teeth [
2
,
8
–
10
], in which fluoride accumulates in
the form of fluorohydroxylapatite and fluoroapatite, replacing hydroxyl ions in the hydroxylapatite
structure [
11
,
12
]. These processes may occur at any point in life, starting as early as in the prenatal
period [
13
–
15
], and their effects are observed even in the skeletons and dentition of archaeological
excavations from the times when exposure to fluorine compounds was incomparably lower to
modern times [
16
–
18
]. Significantly, the deposition of fluoride in hard tissues may have its own
adverse effects. The symptoms of excessive fluoride accumulation in bones and teeth are known and
well documented, classified as skeletal fluorosis and dental fluorosis, respectively [
19
–
24
]. In addition
to deposition in hard tissues, fluoride may also be found in calcification areas in soft tissues such as
the aorta [
25
–
29
], coronary arteries [
30
,
31
], placenta [
32
–
41
], tendons [
42
–
44
], or cartilage [
42
,
45
,
46
].
In these cases
, however, this accumulation may not be classified as a defense mechanism triggered
by an excessive exposure to fluoride. Unlike in hard tissues, calcium accumulation in soft tissues
is never a physiological phenomenon and almost always leads to some undesirable effects, e.g.,
complications in
pregnancy [
47
,
48
]. This indicates that the saturation of soft tissues with fluoride is a
natural consequence of their calcification. On the other hand, fluoride itself may stimulate the formation
of calcification foci in the soft tissues [
27
,
49
], which suggests that fluoride accumulation is the primary
phenomenon in calcification. Yet, regardless of the exact mechanisms, concentration of fluoride in the
bloodstream, and thus the risk of adverse effects in the body, is reduced as fluoride accumulates in the
soft tissues. Obviously, the exceptions to this are the fluoride-accumulating
soft tissues
; for example,
extensive deposits
of calcium fluoride in the placenta may impair blood flow through this organ and
thus impair fetal nutrition [32,33,50,51].
Appl. Sci. 2020,10, 2885; doi:10.3390/app10082885 www.mdpi.com/journal/applsci
Appl. Sci. 2020,10, 2885 2 of 10
One of the most interesting soft tissues able to accumulate fluoride is the pineal gland [
1
,
52
–
55
].
However, while knowledge of the calcification of this organ dates back to the 17th century [
56
],
the first
reports on its accumulation of fluoride appeared only in the mid-1990s [54].
2. Pineal Gland—Anatomy and Physiology
In humans, the pineal gland is a neuroendocrine gland weighing about 150 mg [
57
]. The organ,
part of the epithalamus, is located between the colliculi superiores of the lamina tecti, at the back of the
posterior wall of the third brain ventricle [
58
] (Figure 1). The pineal gland is characterized by a very
rich network of blood vessels, which ensures blood flow of 4 mL/min/g, second only to the blood
supply to the kidneys [
58
–
60
]. Another unique anatomical feature of the gland is its location outside
the blood–brain barrier [
58
,
59
]. Therefore, unlike most other brain structures, the pineal gland has
open access to blood and all of its components. Extremely rich vascularization and no significant
restrictions in transport from the bloodstream make it possible for the pineal gland to accumulate
significant amounts of various substances, mainly, calcium [
58
,
61
–
66
]; microelements such as cobalt,
zinc, and selenium [67]; and fluoride [52–54].
Appl. Sci. 2020, 10, x FOR PEER REVIEW 2 of 10
calcium fluoride in the placenta may impair blood flow through this organ and thus impair fetal
nutrition [32,33,50,51].
One of the most interesting soft tissues able to accumulate fluoride is the pineal gland
[1,52–55]. However, while knowledge of the calcification of this organ dates back to the 17th
century [56], the first reports on its accumulation of fluoride appeared only in the mid-1990s [54].
2. Pineal gland—anatomy and physiology
In humans, the pineal gland is a neuroendocrine gland weighing about 150 mg [57]. The organ,
part of the epithalamus, is located between the colliculi superiores of the lamina tecti, at the back of
the posterior wall of the third brain ventricle [58] (Figure 1). The pineal gland is characterized by a
very rich network of blood vessels, which ensures blood flow of 4 mL/min/g, second only to the
blood supply to the kidneys [58–60]. Another unique anatomical feature of the gland is its location
outside the blood–brain barrier [58,59]. Therefore, unlike most other brain structures, the pineal
gland has open access to blood and all of its components. Extremely rich vascularization and no
significant restrictions in transport from the bloodstream make it possible for the pineal gland to
accumulate significant amounts of various substances, mainly, calcium [58,61–66]; microelements
such as cobalt, zinc, and selenium [67]; and fluoride [52–54].
Figure 1. T1-weighted midline sagittal magnetic resonance imaging (MRI) with an arrow pointing to
a normal pineal gland (case courtesy of Assoc Prof Frank Gaillard, Radiopaedia.org, rID: 10767).
The basic function of the pineal gland is the production and secretion of melatonin [58,64], a
hormone found in all vertebrates [60], including humans, which regulates circadian rhythms such
as the sleep–wake cycle [64] (Figure 2). It is also a strong antioxidant [68–70] and an
anti-inflammatory agent [71,72]. Although melatonin can be synthesized in almost all organs and
tissues, including skin [73], intestines [74], bone marrow [75], testicles [76], ovaries [77], or the
placenta [78], the proper biological response is regulated by the pineal hormone [64].
Figure 2. Chemical structure of melatonin.
Biosynthesis of melatonin (Figure 3) occurs in pinealocytes, which constitute about 95% of the
pineal gland’s volume [79]. The remaining part of the organ consists of astrocytes, microglia,
Figure 1.
T1-weighted midline sagittal magnetic resonance imaging (MRI) with an arrow pointing to a
normal pineal gland (case courtesy of Assoc Prof Frank Gaillard, Radiopaedia.org, rID: 10767).
The basic function of the pineal gland is the production and secretion of melatonin [
58
,
64
],
a hormone
found in all vertebrates [
60
], including humans, which regulates circadian rhythms such as
the sleep–wake cycle [
64
] (Figure 2). It is also a strong antioxidant [
68
–
70
] and an anti-inflammatory
agent [
71
,
72
]. Although melatonin can be synthesized in almost all organs and tissues, including
skin [
73
], intestines [
74
], bone marrow [
75
], testicles [
76
], ovaries [
77
], or the placenta [
78
], the proper
biological response is regulated by the pineal hormone [64].
Appl. Sci. 2020, 10, x FOR PEER REVIEW 2 of 10
calcium fluoride in the placenta may impair blood flow through this organ and thus impair fetal
nutrition [32,33,50,51].
One of the most interesting soft tissues able to accumulate fluoride is the pineal gland
[1,52–55]. However, while knowledge of the calcification of this organ dates back to the 17th
century [56], the first reports on its accumulation of fluoride appeared only in the mid-1990s [54].
2. Pineal gland—anatomy and physiology
In humans, the pineal gland is a neuroendocrine gland weighing about 150 mg [57]. The organ,
part of the epithalamus, is located between the colliculi superiores of the lamina tecti, at the back of
the posterior wall of the third brain ventricle [58] (Figure 1). The pineal gland is characterized by a
very rich network of blood vessels, which ensures blood flow of 4 mL/min/g, second only to the
blood supply to the kidneys [58–60]. Another unique anatomical feature of the gland is its location
outside the blood–brain barrier [58,59]. Therefore, unlike most other brain structures, the pineal
gland has open access to blood and all of its components. Extremely rich vascularization and no
significant restrictions in transport from the bloodstream make it possible for the pineal gland to
accumulate significant amounts of various substances, mainly, calcium [58,61–66]; microelements
such as cobalt, zinc, and selenium [67]; and fluoride [52–54].
Figure 1. T1-weighted midline sagittal magnetic resonance imaging (MRI) with an arrow pointing to
a normal pineal gland (case courtesy of Assoc Prof Frank Gaillard, Radiopaedia.org, rID: 10767).
The basic function of the pineal gland is the production and secretion of melatonin [58,64], a
hormone found in all vertebrates [60], including humans, which regulates circadian rhythms such
as the sleep–wake cycle [64] (Figure 2). It is also a strong antioxidant [68–70] and an
anti-inflammatory agent [71,72]. Although melatonin can be synthesized in almost all organs and
tissues, including skin [73], intestines [74], bone marrow [75], testicles [76], ovaries [77], or the
placenta [78], the proper biological response is regulated by the pineal hormone [64].
Figure 2. Chemical structure of melatonin.
Biosynthesis of melatonin (Figure 3) occurs in pinealocytes, which constitute about 95% of the
pineal gland’s volume [79]. The remaining part of the organ consists of astrocytes, microglia,
Figure 2. Chemical structure of melatonin.
Biosynthesis of melatonin (Figure 3) occurs in pinealocytes, which constitute about 95%
of the pineal gland’s volume [
79
]. The remaining part of the organ consists of astrocytes,
microglia,
vascular endothelial cells
, and nerve fibers [
79
,
80
]. The precursor of melatonin is
Appl. Sci. 2020,10, 2885 3 of 10
tryptophan [
58
],
and most
of the hormone is produced during sleep [
81
]. Its plasma concentration
reaches its maximum between 2 and 3 o’clock in the morning (80–150 pg/mL) [
82
].
The mechanism
conditioning this effect is initiated by reducing the activity of the suprachiasmatic nuclei,
which occurs
at night
. The effect is the activation of postganglionic sympathetic fibers and the release
of norepinephrine
from their nerve endings. This neurotransmitter stimulates
β
-adrenergic receptors, inducing activation
of the adenylate cyclase-cyclic adenosine monophosphate (AMP) system.
As a result of
the increased
cyclic adenosine monophosphate (cAMP) concentration in pinealocyte cytosol, the activity of serotonin
N-acetyltransferase increases, which leads to the stimulation of melatonin synthesis [83,84].
Appl. Sci. 2020, 10, x FOR PEER REVIEW 3 of 10
vascular endothelial cells, and nerve fibers [79,80]. The precursor of melatonin is tryptophan [58],
and most of the hormone is produced during sleep [81]. Its plasma concentration reaches its
maximum between 2 and 3 o’clock in the morning (80–150 pg/mL) [82]. The mechanism
conditioning this effect is initiated by reducing the activity of the suprachiasmatic nuclei, which
occurs at night. The effect is the activation of postganglionic sympathetic fibers and the release of
norepinephrine from their nerve endings. This neurotransmitter stimulates β-adrenergic receptors,
inducing activation of the adenylate cyclase-cyclic adenosine monophosphate (AMP) system. As a
result of the increased cyclic adenosine monophosphate (cAMP) concentration in pinealocyte
cytosol, the activity of serotonin N-acetyltransferase increases, which leads to the stimulation of
melatonin synthesis [83,84].
Figure 3. Biosynthesis of melatonin.
3. Calcium accumulation in the pineal gland
Calcium accumulates in the pineal gland in the apatite structure, similar to that found in bones
and teeth [63,85,86], and as calcium carbonate (calcite) [87]. The process is initiated in childhood
[88], and even in newborns [89,90], so some scientists see it as a physiological phenomenon [64]. It
is, however, difficult to agree with such a conviction in the face of ample evidence showing the
relationship between pineal calcification and various pathological states. This includes mental
illnesses and disorders [91–93], neurodegenerative disorders [94,95], primary brain tumors [96],
ischemic stroke [97], migraine [98], and sleep disorders [99]. The accumulation of calcium in the
pineal gland is also related to aging processes [100] (Figure 4).
Figure 4. Computer tomography (CT) scan through the brain with calcification of the pineal gland
(case courtesy of Radswiki, Radiopaedia.org, rID: 11770).
Figure 3. Biosynthesis of melatonin.
3. Calcium Accumulation in the Pineal Gland
Calcium accumulates in the pineal gland in the apatite structure, similar to that found in bones
and teeth [
63
,
85
,
86
], and as calcium carbonate (calcite) [
87
]. The process is initiated in childhood [
88
],
and even
in newborns [
89
,
90
], so some scientists see it as a physiological phenomenon [
64
].
It is
,
however, difficult to agree with such a conviction in the face of ample evidence showing the relationship
between pineal calcification and various pathological states. This includes mental illnesses and
disorders [
91
–
93
], neurodegenerative disorders [
94
,
95
], primary brain tumors [
96
], ischemic stroke [
97
],
migraine [
98
], and sleep disorders [
99
]. The accumulation of calcium in the pineal gland is also related
to aging processes [100] (Figure 4).
Appl. Sci. 2020, 10, x FOR PEER REVIEW 3 of 10
vascular endothelial cells, and nerve fibers [79,80]. The precursor of melatonin is tryptophan [58],
and most of the hormone is produced during sleep [81]. Its plasma concentration reaches its
maximum between 2 and 3 o’clock in the morning (80–150 pg/mL) [82]. The mechanism
conditioning this effect is initiated by reducing the activity of the suprachiasmatic nuclei, which
occurs at night. The effect is the activation of postganglionic sympathetic fibers and the release of
norepinephrine from their nerve endings. This neurotransmitter stimulates β-adrenergic receptors,
inducing activation of the adenylate cyclase-cyclic adenosine monophosphate (AMP) system. As a
result of the increased cyclic adenosine monophosphate (cAMP) concentration in pinealocyte
cytosol, the activity of serotonin N-acetyltransferase increases, which leads to the stimulation of
melatonin synthesis [83,84].
Figure 3. Biosynthesis of melatonin.
3. Calcium accumulation in the pineal gland
Calcium accumulates in the pineal gland in the apatite structure, similar to that found in bones
and teeth [63,85,86], and as calcium carbonate (calcite) [87]. The process is initiated in childhood
[88], and even in newborns [89,90], so some scientists see it as a physiological phenomenon [64]. It
is, however, difficult to agree with such a conviction in the face of ample evidence showing the
relationship between pineal calcification and various pathological states. This includes mental
illnesses and disorders [91–93], neurodegenerative disorders [94,95], primary brain tumors [96],
ischemic stroke [97], migraine [98], and sleep disorders [99]. The accumulation of calcium in the
pineal gland is also related to aging processes [100] (Figure 4).
Figure 4. Computer tomography (CT) scan through the brain with calcification of the pineal gland
(case courtesy of Radswiki, Radiopaedia.org, rID: 11770).
Figure 4.
Computer tomography (CT) scan through the brain with calcification of the pineal gland
(case courtesy of Radswiki, Radiopaedia.org, rID: 11770).
In the study in adolescents and adults, Kunz et al. [
61
] demonstrated an inverse correlation between
the degree of pinealocyte calcification and pinealocyte count. Although there was no significant
Appl. Sci. 2020,10, 2885 4 of 10
correlation between gland calcification and plasma melatonin concentration, it was noted that the
reduction in pinealocyte count caused by calcification was accompanied by a reduction in melatonin
synthesis. Hence, the conclusion that pineal gland calcification has an indirect effect on the production
and secretion of this hormone. These observations were confirmed by Liebrich et al. [
101
], who,
using magnetic
resonance imaging, showed a positive correlation between the size of the uncalcified
part of the pineal gland and the concentration of melatonin in saliva.
According to some authors, the concentration of melatonin in the cerebrospinal fluid plays a
decisive role in the regulation of circadian rhythms, while plasma hormone concentrations are of little
importance in exerting biological effects in this respect [102,103]. As pineal calcification results in the
reduction of melatonin concentration in the cerebrospinal fluid, its relation to diseases of the central
nervous system becomes understandable. The pathomechanism of this relationship is to reduce the
antioxidant effects of melatonin, which favors neuronal damage by reactive oxygen species (ROS) and,
thus, to accelerate the development of neurodegenerative changes [
64
,
70
]. For example, it has been
found that the concentration of melatonin in the cerebrospinal fluid in Alzheimer’s disease is only 20%
of that recorded in healthy individuals [104].
4. Fluoride Accumulation in the Pineal Gland and Its Consequences
Both calcified and calcium-free areas of the pineal gland undergo mineralization and accumulate,
among other things, magnesium, iron, manganese, zinc, strontium, orcopper [
105
]. However,
it was
not
until the 1990s that it was discovered that the foci of calcification within the gland may be accompanied
by extremely high concentrations of fluoride for soft tissue [
54
]. In 2001, Luke [
52
] first published the
results of fluoride concentration measurements in pineal glands taken from
human corpses
.
The mean
concentration was 297 mg F/kg of wet weight (ww), but the range of recorded values was very wide
(14 mg/kg–875 mg/kg ww). It is not difficult to notice that they are similar or even higher than those
observed in bones and teeth and many times exceed the concentrations observed in other soft tissues
(e.g., in muscles, they are about 1 mg F/kg ww). After converting these values into dry weight (dw),
we obtain
concentrations of 1485 +1285 mg F/kg dw. Although these data come from older individuals
(studies were conducted on a group of deceased people aged 70 to 100 years), this does not disprove
the idea that the pineal gland may be considered the most fluoride-saturated organ of the human body.
It has been observed that the fluoride content in pineal gland apatite is higher than in any other natural
apatite and may even reach 21000 mg/kg [52,53].
The results of Luke’s research also revealed a strong positive correlation between calcium and
fluoride concentrations (r =0.73, p<0.02) [
52
]. Ten or so years later this observation was confirmed,
albeit not for the full range of fluoride concentrations. Tharnpanich et al. [
53
] demonstrated that
a statistically significant correlation occurs only when the fluoride concentration exceeds 50 mg/kg
of fresh gland tissue. They recorded the values of these concentrations, which ranged anywhere
from
0 mg F/kg ww
to 831 mg F/kg ww (mean 75.5 +228 mg F/kg ww). This suggests that the
accumulation of fluoride in the pineal gland is rather a secondary phenomenon to the primary
calcification of this organ and at some point the relation between them reaches the status of a very
strong positive correlation (r =0.915, p<0.001). It is also worth noting that pineal glands in the study
by Tharnpanich et al. [
53
] were collected from deceased persons aged 33 to 91 years (mean 67 years),
who had inhabited an area with low fluoride contamination, which is a strong argument for the idea
that a smaller or larger accumulation of fluoride in the gland occurs even when the organism is not
exposed to particularly large amounts of fluorine compounds in the environment.
Regardless of how accumulation of fluoride in the pineal gland takes place, whether this is primary
or secondary to calcification, the most important issue is the effects of this phenomenon. It is obvious
that they will primarily concern the physiological function of the gland.
Assuming the preferential accumulation of fluoride in the pineal gland and the related possible
risk of toxic effects, Malin et al. [
11
] have recently published a study on the processes of sleep regulation
among older adults in the United States. They tried to answer the question of whether chronic exposure
Appl. Sci. 2020,10, 2885 5 of 10
to low doses of fluoride has an effect on sleep patterns and daytime sleepiness in the studied population.
The study investigated adolescents aged 16–19 years (mean =17 years), who had declared that they
had no sleeping disorders, who were exposed to low doses of fluoride (mean concentration in drinking
water =0.39 mg/L), and who had low concentrations of fluoride in plasma (mean =0.35
µ
mol/L).
Higher water fluoride levels were connected with higher odds of participants reporting snorting,
gasping, or apnea, while sleeping at night. Additionally, adolescents who lived in areas with higher
fluoride levels in tap water experienced more frequent daytime sleepiness. The authors [
11
] were of the
opinion that fluoride exposure may contribute to increased pineal gland calcification and subsequent
decreases in nighttime melatonin production that contribute to sleep disturbances.
For obvious reasons, there are very few reports on the accumulation of fluoride in the pineal gland
and its effect on the functionality of the organ in humans. Therefore, it is worth noting the studies
carried out in both experimental and free-living animals.
In the pineal glands taken from the common merganser (Mergus merganser), Kalisi´nska et al. [
1
]
recorded very high fluoride contents (mean >1000 mg/kg dw), which even exceed the concentrations
observed in the bones of these birds. Such a high concentration of fluoride in the gland is explained
by the incompleteness of the blood–brain barrier in birds, which facilitates the penetration of various
substances into the central nervous system.
Mrvelj and Womble [
79
] conducted a study to determine the effect of fluoride removal from the
diet of aged rats (over 26 months of age) on the pineal cell structure and to compare the results with
rats receiving fluoride with food (control). It was observed that in animals deprived of fluoride for
8 weeks, the number of pinealocytes was higher than in control animals, which suggests a harmful
effect of fluoride contained in the diet on pineal morphology and thus on the production and secretion
of melatonin.
In turn, studies conducted by Bharti and Srivastava [
106
,
107
] in rats showed the beneficial
effect of melatonin and pineal proteins on fluoride-induced oxidative stress, which is one of the
best known effects of fluoride on the body [
108
,
109
]. The animals were exposed to different
doses of fluoride and melatonin and proteins obtained from buffalo pineal (Bubalus bubalis).
The severity
of oxidative stress was measured by the degree of activity of antioxidative enzymes:
superoxide dismutase (SOD)
,
catalase (CAT)
, glutathione peroxidase (GPx), glutathione reductase
(GR), as well as the concentration of reduced glutathione (GSH) and malondialdehyde (MDA) in the
brains of the animals [
6
].
The antioxidant
system parameters were markedly improved by the intake
of melatonin and
pineal proteins
; in the latter case, the beneficial effect was even stronger. The action
consisted of increased activity of antioxidant enzymes, increased GSH concentration, and decreased
MDA concentration
. All these parameters were adversely affected in the group of animals receiving
fluoride only (decreased activity of enzymes and GSH concentration and increased MDA concentration,
which is a marker of increased oxidative stress), painting a very disturbing picture of the effects of
fluoride accumulation in the pineal gland. Since it is known that fluoride reduces the production and
secretion of melatonin [
79
], a substance which reduces the oxidative stress induced by them [
107
],
the accumulation
of fluoride in the pineal gland may be a significant factor in enhancing the effects of
reactive oxygen species, with all potential adverse consequences.
Finally, it is worth mentioning that the concentrations of fluoride in the pineal gland at the
magnitude of several dozen or even several hundred mg/kg ww, revealed in the studies by Luke [
52
]
and Tharnpanich et al. [
53
], may show inhibitory activity on melatonin synthesis pathway enzymes.
Fluoride having this effect has been known for a long time in relation to many enzymes [
108
,
110
].
Thus, it cannot be excluded that the restriction of melatonin synthesis associated with pinealocyte
calcification may be caused not only by a decrease in the number of active pinealocytes but also by the
direct influence of fluoride accumulated in the gland on enzymatic activity. This issue undoubtedly
needs to be clarified in the future.
Author Contributions:
Both authors contributed equally in this article. All authors have read and agreed to the
published version of the manuscript.
Appl. Sci. 2020,10, 2885 6 of 10
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1.
Kalisi ´nska, E.; Baranowska-Bosiacka, I.; Łanocha, N.; Kosik-Bogacka, D.; Kr
ó
laczyk, K.; Wilk, A.; Kavetska, K.;
Budis, H.; Gutowska, I.; Chlubek, D. Fluoride concentrations in the pineal gland, brain and bone of goosander
(Mergus merganser) and its prey in Odra River estuary in Poland. Environ. Geochem. Health
2014
,36, 1063–1077.
[CrossRef] [PubMed]
2.
Kanduti, D.; Sterbenk, P.; Artnik, B. Fluoride: A review of use and effects on health. Mater. Sociomed.
2016
,
28, 133–137. [CrossRef]
3.
Kupnicka, P.; Kojder, K.; Metryka, E.; Kapczuk, P.; Je˙zewski, D.; Gutowska, I.; Goschorska, M.; Chlubek, D.;
Baranowska-Bosiacka, I. Morphine-element interactions—The influence of selected chemical elements on
neural pathways associated with addiction. J. Trace Elem. Med. Biol. 2020,60, 126495. [CrossRef]
4.
Choi, A.L.; Sun, G.; Zhang, Y.; Grandjean, P. Developmental fluoride neurotoxicity: A systematic review and
meta-analysis. Environ. Health Perspect. 2012,10, 1362–1368. [CrossRef]
5.
Dec, K.; Łukomska, A.; Maciejewska, D.; Jakubczyk, K.; Baranowska-Bosiacka, I.; Chlubek, D.; W ˛asik, A.;
Gutowska, I. The influence of fluorine on the disturbances of homeostasis in the central nervous system.
Biol. Trace Elem. Res. 2017,177, 224–234. [CrossRef]
6.
Duan, Q.; Jiao, J.; Chen, X.; Wang, X. Association between water fluoride and the level of
children’s intelligence
:
A dose-response meta-analysis. Public Health 2018,154, 87–97. [CrossRef]
7.
Ghosh, A.; Mukherjee, K.; Ghosh, S.K.; Saha, B. Sources and toxicity of fluoride in the environment.
Res. Chem. Intermediat. 2013,39, 2881–2915. [CrossRef]
8.
Palczewska-Komsa, M.; Barczak, K.; Kotwas, A.; Sikora, M.; Chlubek, D.; Buczkowska-Radli´nska, J. Fluoride
concentration in dentin of human permanent teeth. Fluoride 2019,52, 489–496.
9.
Waszkiel, D.; Opalko, K.; Łagocka, R.; Chlubek, D. Fluoride and magnesium content in superficial enamel
layers of teeth with erosions. Fluoride 2004,37, 285–291.
10. Buzalaf, M.A.; Whitford, G.M. Fluoride metabolism. Monogr. Oral Sci. 2011,22, 20–36. [PubMed]
11.
Malin, A.J.; Bose, S.; Busgang, S.A.; Gennings, C.; Thorpy, M.; Wright, R.O.; Wright, R.J.; Arora, M.
Fluoride exposure
and sleep patterns among older adolescents in the United States: A cross-sectional study
of NHANES 2015–2016. Environ. Health 2019,18, 106. [CrossRef] [PubMed]
12.
ten Cate, J.M.; Featherstone, J.D. Mechanistic aspects of the interactions between fluoride and dental enamel.
Crit. Rev. Oral Biol. Med. 1991,2, 283–296. [CrossRef] [PubMed]
13. Mokrzy ´nski, S.; Machoy, Z. Fluoride incorporation into fetal bone. Fluoride 1994,27, 151–154.
14.
Mokrzy´nski, S.; Chlubek, D.; Mikulski, T.; Machoy, Z. The use of microdensitometric examinations for
evaluating the influence of fluorine on bone mineralization in fetus. Pol. Przegl. Radiol. 1994,58, 62–64.
15.
Mokrzy´nski, S.; Chlubek, D.; Machoy, Z.; Samujło, D. Fluoride in the organism of mother and fetus. II.
Fluoride cumulation in the organism of fetus. Ginekol. Pol. 1994,65, 678–681. [PubMed]
16.
Sikora, M.; Kwiatkowska, B.; Chlubek, D. Fluoride content in superficial enamel layers of human teeth from
archeological excavations. Fluoride 2014,47, 341–348.
17.
Chlubek, D.; Noce´n, I.; D ˛abkowska, E.; ˙
Zyluk, B.; Machoy, Z.; Kwiatkowska, B. Fluoride accumulation in
human skulls in relation to chronological age. Fluoride 1996,29, 131–134.
18.
Chlubek, D.; Sikora, M.; Kwiatkowska, B.; Gronkiewicz, S. Determinations of mineral composition in
superficial enamel layers of human teeth from archeological excavations by means of enamel biopsy.
Biul. Magnezol. 2001,6, 110–117.
19. Patil, M.M.; Lakhkar, B.B.; Patil, S.S. Course of fluorosis. Indian J. Pediatr. 2018,85, 375–383. [CrossRef]
20.
Shruthi, M.N.; Anil, N.S. A comparative study of dental fluorosis and non-skeletal manifestations of fluorosis
in areas with different water fluoride concentrations in rural Kolar. J. Family Med. Prim. Care.
2018
,7,
1222–1228.
21.
Rajapakse, P.S.; Jayawardhane, W.M.; Lokubandara, A.; Gamage, R.; Dasanayake, A.P.; Goonaratna, C.
High prevalence
of dental fluorosis among schoolchildren in three villages in Vavuniya District:
An observational study. Ceylon Med. J. 2017,62, 218–221. [CrossRef] [PubMed]
Appl. Sci. 2020,10, 2885 7 of 10
22.
Hewavithana, P.B.; Jayawardhane, W.M.; Gamage, R.; Goonaratna, C. Skeletal fluorosis in Vavuniya District:
An observational study. Ceylon Med. J. 2018,63, 139–142. [CrossRef] [PubMed]
23.
Sellami, M.; Riahi, H.; Maatallah, K.; Ferjani, H.; Bouaziz, M.C.; Ladeb, M.F. Skeletal fluorosis: Don’t miss
the diagnosis! Skeletal Radiol. 2020,49, 345–357. [CrossRef] [PubMed]
24.
Aoba, T.; Fejerskov, O. Dental fluorosis: Chemistry and biology. Crit. Rev. Oral Biol. Med.
2002
,13, 155–170.
[CrossRef]
25.
Waldbott, G.L. Fluoride and calcium levels in the aorta. Exeprientia
1966
,22, 835–837. [CrossRef] [PubMed]
26.
Zipkin, I.; Zucas, S.M.; Lavender, D.R.; Fullmer, H.M.; Schiffmann, E.; Corcoran, B.A. Fluoride and calcification
of rat aorta. Calcif. Tissue Res. 1970,6, 173–182. [CrossRef] [PubMed]
27.
Susheela, A.K.; Kharb, P. Aortic calcification in chronic fluoride poisoning: Biochemical and
electronmicroscopic evidence. Exp. Mol. Pathol. 1990,53, 72–80. [CrossRef]
28.
Fiz, F.; Morbelli, S.; Bauckneht, M.; Piccardo, A.; Ferrarazzo, G.; Nieri, A.; Artom, N.; Cabria, M.; Marini, C.;
Canepa, M.; et al. Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk.
World J. Radiol. 2016,8, 82–89. [CrossRef]
29.
Ericsson, Y.; Hammarström, L. Autoradiographic localization of fluoride and calcium deposition in the
atherosclerotic aorta of cholesterol-fed rabbits. Gerontology 1964,9, 150–156. [CrossRef]
30.
Li, Y.; Berenji, G.R.; Shaba, W.F.; Tafti, B.; Yevdayev, E.; Dadparvar, S. Association of vascular fluoride uptake
with vascular calcification and coronary artery disease. Nucl. Med. Commun. 2012,33, 14–20. [CrossRef]
31.
Chen, W.; Dilsizian, V. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: Microcalcification
with sodium fluoride and inflammation with fluorodeoxyglucose. Curr. Cardiol. Rep.
2013
,15, 364.
[CrossRef]
32.
Chlubek, D.; Por˛eba, R.; Machali´nski, B. Fluoride and calcium distribution in human placenta. Fluoride
1998
,
31, 131–136.
33.
Chlubek, D.; Rzeuski, R. Toxic effects of fluorine compounds on the fetus and their effect on the course
of pregnancy. Ginekol. Pol. 1996,67, 141–418.
34.
Shen, Y.W.; Taves, D.R. Fluoride concentrations in human placenta and maternal and cord blood. Am. J.
Obstet. Gynecol. 1974,119, 205–207. [CrossRef]
35.
Gurumurthy, S.M.; Mohanty, S.; Vyakaranam, S.; Bhongir, A.V.; Rao, P. Transplacental transport of fluoride,
calcium and magnesium. Natl. J. Integr. Res. Med. 2011,2, 51–55.
36.
Gurumurthy, S.M.; Mohanty, S.; Rao, P. Role of placenta to combat fluorosis (in fetus) in endemic
fluorosis area
.
Natl. J. Integr. Res. Med. 2010,1, 16–19.
37.
Chlubek, D.; Machoy, Z.; Samujło, D. Fluoride concentration in human placenta in the region of fluorine
industrial emissions. Bromat. Chem. Toksykol. 1997,30, 299–302.
38.
Feltman, R.; Kosel, G. Prenatal ingestion of fluorides and their transfer to the fetus. Science
1955
,122, 560–561.
[CrossRef]
39. Chlubek, D.; Machoy, Z. Role of placenta in fluoride metabolism. Ginekol. Pol. 1991,42, 568–572.
40.
Chlubek, D. Some aspects of prenatal fluoride metabolism in humans. Studies performed during the
perinatal period. Ann. Acad. Med. Stetin. 1996,42 (Suppl. S31), 1–99.
41.
Chlubek, D.; Zawierta, J.; Ka´zmierczyk, A.; Kramek, J.; Olszewska, M.; Stachowska, E. Effect of different
fluoride ion concentrations on malondialdehyde (MDA) formation in the mitochondrial fraction of human
placental cells. Bromat. Chem. Toksykol. 1999,32, 119–122.
42.
Kot, K.; Ciosek, ˙
Z.; Łanocha-Arendarczyk, N.; Kosik-Bogacka,D.; Zi ˛etek, P.; Karaczun, G.; Baranowska-Bosiacka, I.;
Gutowska, I.; Kalisi´nska, E.; Chlubek, D. Fluoride concentrations in cartilage, spongy bone, anterior
cruciate ligament, meniscus, and infrapatellar fat pad of patients undergoing primary knee
joint arthroplasty. Fluoride 2017,50, 175–181.
43. Giachini, M.; Pierleoni, F. Fluoride toxicity. Minerva Stomatol. 2004,53, 171–177. [PubMed]
44.
Fordyce, F.M.; Vrana, K.; Zhovinsky, E.; Povoroznuk, V.; Toth, G.; Hope, B.C.; Iljinsky, U.; Baker, J. A health
risk assessment for fluoride in Central Europe. Environ. Geochem. Health 2007,29, 83–102. [CrossRef]
45.
Kosik-Bogacka, D.; Łanocha-Arendarczyk, N.; Kot, K.; Zi˛etek, P.; Karaczun, M.; Gutowska, I.;
Baranowska-Bosiacka, I.; Grzeszczak, K.; Sikora, M.; Chlubek, D. Fluoride concentration in synovial
fluid, bone marrow, and cartilage in patients with osteoarthritis. Fluoride 2018,51, 164–170.
46.
Doł˛egowska, B.; Machoy, Z.; Chlubek, D. Changes in the content of zinc and fluoride during growth of the
femur in chicken. Biol. Trace Elem. Res. 2003,91, 67–76. [CrossRef]
Appl. Sci. 2020,10, 2885 8 of 10
47.
Jamal, A.; Moshfeghi, M.; Moshfeghi, S.; Mohammadi, N.; Zarean, E.; Jahangiri, N. Is preterm placental
calcification related to adverse maternal and foetal outcome? J. Obstet. Gynecol.
2017
,37, 605–609. [CrossRef]
48.
Moran, M.; Higgins, M.; Zombori, G.; Ryan, J.; McAuliffe, F.M. Computerized assessment of placental
calcification post-ultrasound: A novel software tool. Ultrasound Obstet. Gynecol.
2013
,41, 545–549. [CrossRef]
49.
Wang, W.; Kong, L.; Zhao, H.; Dong, R.; Li, J.; Jia, Z.; Ji, N.; Deng, S.; Sun, Z.; Zhou, J. Thoracic ossification of
ligamentum flavum caused by skeletal fluorosis. Eur. Spine J. 2007,16, 1119–1128. [CrossRef]
50.
Chlubek, D.; Mokrzy´nski, S.; Machoy, Z.; Samujło, D.; W˛egrzynowski, J. Fluoride concentration in mother
and fetus. I. Placental transport of fluorides. Ginekol. Pol. 1994,65, 611–615.
51.
Chlubek, D.; Mokrzy ´nski, S.; Machoy, Z.; Olszewska, M. Fluorides in the body of mother and in the fetus. III.
Fluorides in amniotic fluid. Ginekol Pol. 1995,66, 614–617.
52. Luke, J. Fluoride deposition in the aged human pineal gland. Caries Res. 2001,35, 125–128. [CrossRef]
53.
Tharnpanich, T.; Johns, J.; Subongkot, S.; Johns, N.P.; Kitkhuandee, A.; Toomsan, Y.; Luengpailin, S. Association
between high pineal fluoride content and pineal calcification in a low fluoride area.
Fluoride 2016,49, 472–484.
54.
Luke, J. The Effect of Fluoride on the Physiology of the Pineal Gland. Ph.D. Thesis, University of Surrey,
Guildford, UK, 1997.
55.
National Research Council. Fluoride in Drinking Water: A Scientific Review of EPAs Standards; Advisors of
the Nation on Science Engineering and Medicine; Committee on Fluoride in Drinking Water; Board on
Environmental Studies and Toxicology; The National Academies: Washington, DC, USA, 2006; pp. 262–263.
56.
Del Rio-Hortega, P. Cytology and cellular pathology of the nervous system. In Pineal Gland; Penfield, W., Ed.;
Hoeber: New York, NY, USA, 1932; pp. 637–703.
57.
Golan, J.; Torres, K.; Sta´skiewicz, G.J.; Opielak, G.; Maciejewski, R. Morphometric parameters of the human
pineal gland in relation to age, body weight and height. Folia Morphol. 2002,61, 111–113.
58.
Macchi, M.M.; Bruce, J.N. Human pineal physiology and functional significance of melatonin.
Front. Neuroendocrinol. 2004,25, 177–195. [CrossRef]
59. Arendt, J. Melatonin and the Mammalian Pineal Gland, 1st ed.; Chapman & Hall: London, UK, 1995; p. 17.
60.
Tan, D.-X.; Manchester, L.C.; Fuentes-Broto, L.; Paredes, S.D.; Reiter, R.J. Significance and application of
melatonin in the regulation of brown adipose tissue metabolism. Relation to human obesity. Obes. Rev.
2011
,
12, 167–188. [CrossRef]
61.
Kunz, D.; Schmitz, S.; Mahlberg, R.; Mohr, A.; Stöter, C.; Wolf, K.J.; Herrmann, W.M. A new concept for
melatonin deficit: On pineal calcification and melatonin excretion. Neuropsychopharmacology
1999
,21, 765–772.
[CrossRef]
62.
Mahlberg, R.; Kienast, T.; Hödel, S.; Heidenreich, J.O.; Schmitz, S.; Kunz, D. Degree of pineal calcification
(DOC) is associated with polysomnographic sleep measures in primary insomnia patients. Sleep Med.
2009
,
10, 439–445. [CrossRef]
63.
Patel, S.; Rahmani, B.; Gandhi, J.; Seyam, O.; Joshi, G.; Reid, I.; Smith, N.L.; Waltzer, W.C.; Khan, S.A.
Revisiting the pineal gland: A review of calcification, masses, precocious puberty, and melatonin functions.
Int. J. Neurosci. 2020,25, 1–12. [CrossRef]
64.
Tan, D.-X.; Xu, B.; Zhou, X.; Reiter, R.J. Calcification, melatonin production, aging, associated health
consequences and rejuvenation of the pineal gland. Molecules 2018,23, 301. [CrossRef]
65.
Kiro˘glu, Y.; Çalli, C.; Karabulut, N.; Oncel, C. Intracranial calcifications on CT. Diagn. Interv. Radiol.
2010
,16,
263–269.
66.
McKinney, A.M. Atlas of Normal Imaging Variations of the Brain, Skull, and Craniocervical Vasculature; Springer
International Publishing: Cham, Switzerland, 2017.
67.
Demmel, U.; Höck, A.; Kasperek, K.; Feinendegen, L.E. Trace element concentration in the human pineal
body. Activation analysis of cobalt, iron, rubidium, selenium, zinc, antimony and cesium. Sci. Total Environ.
1982,24, 135–146. [CrossRef]
68.
Reiter, R.J.; Mayo, J.C.; Tan, D.-X.; Sainz, R.M.; Alatorre-Jimenez, M.; Qin, I. Melatonin as an antioxidant:
Under promises but over delivers. J. Pineal Res. 2016,61, 253–278. [CrossRef]
69.
Reiter, R.J. Oxidative damage in the central nervous system: Protection by melatonin. Prog. Neurobiol.
1998
,
56, 359–384. [CrossRef]
70.
Pandi-Perumal, S.R.; BaHammam, A.S.; Brown, G.M.; Spence, D.W.; Bharti, W.K.; Kaur, C.;
Hardeland, R.; Cardinali, D.P. Melatonin antioxidative defense: Therapeutical implications for aging
and neurodegenerative processes. Neurotox. Res. 2013,23, 267–300. [CrossRef]
Appl. Sci. 2020,10, 2885 9 of 10
71.
Liu, Z.; Gan, L.; Xu, Y.; Luo, D.; Ren, Q.; Wu, S.; Sun, C. Melatonin alleviates inflammasome-induced
pyroptosis through inhibiting NF-
κ
B/GSDMD signal in mice adipose tissue. J. Pineal Res.
2017
,63, e12414.
[CrossRef]
72.
Hardeland, R.; Cardinali, D.P.; Brown, G.M.; Pandi-Perumal, S.R. Melatonin and brain inflammaging.
Prog. Neurobiol. 2015,127–128, 46–63. [CrossRef]
73.
Slominski, A.T.; Zmijewski, M.A.; Semak, I.; Kim, T.K.; Janjetovic, Z.; Slominski, R.M.; Zmijewski, J.W.
Melatonin, mitochondria, and the skin. Cell. Mol. Life Sci. 2017,74, 3913–3925. [CrossRef]
74.
Reiter, R.J.; Rosales-Corral, S.; Boga, J.A.; Tan, D.-X.; Davis, J.M.; Konturek, P.C.; Konturek, S.J.; Brzozowski, T.
The photoperiod, circadian regulation and chronodisruption: The requisite interplay between the
suprachiasmatic nuclei and the pineal and gut melatonin. J. Physiol. Pharmacol. 2011,62, 269–274.
75.
Conti, A.; Conconi, S.; Hertens, E.; Skwarlo-Sonta, K.; Markowska, M.; Maestroni, J.M. Evidence for melatonin
synthesis in mouse and human bone marrow cells. J. Pineal Res. 2000,28, 193–202. [CrossRef]
76.
Tijmes, M.; Pedraza, R.; Valladares, I. Melatonin in the rat testis: Evidence for local synthesis. Steroids
1996
,
61, 65–68. [CrossRef]
77.
Itoh, M.T.; Ishizuka, B.; Kudo, Y.; Fusama, S.; Amemiya, A.; Sumi, Y. Detection of melatonin and serotonin
N-acetyltransferase and hydroxyindole-O-methyltransferase activities in rat ovary. Mol. Cell. Endocrinol.
1997,136, 7–13. [CrossRef]
78.
Soliman, A.; Lacasse, A.-A.; Lanoix, D.; Sagrillo-Fagundes, L.; Boulard, V.; Vaillancourt, C. Placental melatonin
system is present throughout pregnancy and regulates villous trophoblast differentiation. J. Pineal Res.
2015
,
59, 38–46. [CrossRef] [PubMed]
79.
Mrvelj, A.; Womble, M.D. Fluoride-free diet stimulates pineal growth in aged male rats. Biol. Trace Elem. Res.
2020. (In press) [CrossRef]
80.
Ibañez Rodriguez, M.P.; Noctor, S.C.; Muñoz, E.M. Cellular basis of pineal gland development: Emerging
role of microglia as phenotype regulator. PLoS ONE 2016,11, e0167063. [CrossRef]
81.
Murcia Garcia, J.; Muñoz Hovos, A.; Molina Carballo, A.; Fern
á
ndez Garcia, J.M.; Narbona L
ó
pez, E.;
Uberos Fernández, J. Puberty and melatonin. An. Esp. Pediatr. 2002,57, 121–126. [CrossRef]
82.
Lewy, A.J.; Cutler, N.L.; Sack, R.L. The endogenous melatonin profile as a marker for circadian phase position.
J. Biol. Rhythms 1999,14, 227–236. [CrossRef]
83.
Selmaoui, B.; Touitou, Y. Reproducibility of the circadian rhythms of serum cortisol and melatonin in
healthy subjects:
A study of three different 24-h cycles over six weeks. Life Sci.
2003
,73, 3339–3349.
[CrossRef]
84.
Van Someren, E.; Nagtegaal, E. Improving melatonin circadian phase estimates. Sleep Med.
2007
,8, 590–601.
[CrossRef]
85.
Bocchi, G.V.G. Physical, chemical, and mineralogical characterization of carbonatehydroxyapatite concretions
of the human pineal gland. J. Inorg. Biochem. 1993,49, 209–220. [CrossRef]
86.
Mabie, C.P.; Wallace, M.M. Optical, physical and chemical properties of pineal gland calcifications.
Calcif. Tissue Res. 1974,16, 59–71. [CrossRef] [PubMed]
87. Baconnier, S.; Lang, S.B.; Polomska, M.; Hilczer, B.; Berkovic, G.; Meshulam, G. Calcite microcrystals in the
pineal gland of the human brain: First physical and chemical studies. Bioelectromagnetics
2002
,23, 488–495.
[CrossRef] [PubMed]
88.
Doyle, A.J.; Anderson, G.D. Physiologic calcification of the pineal gland in children on computed tomography:
Prevalence, observer reliability and association with choroid plexus calcification. Acad. Radiol.
2006
,13,
822–826. [CrossRef] [PubMed]
89.
Winkler, P.; Helmke, K. Age-related incidence of pineal gland calcification in children: A roentgenological
study of 1044 skull films and a review of the literature. J. Pineal Res. 1987,4, 247–252. [CrossRef]
90.
Ma´sli´nska, D.; Laure-Kamionowska, M.; Der˛egowski, K.; Ma´sli ´nski, S. Association of mast cells with
calcification in the human pineal gland. Folia Neuropathol. 2010,48, 276–282.
91. Kay, S.R.; Sandyk, R. Experimental models of schizophrenia. Int. J. Neurosci. 1991,58, 69–82. [CrossRef]
92.
Sandyk, R.; Kay, S.R. Abnormal EEG and calcification of the pineal gland in schizophrenia. Int. J. Neurosci.
1992,62, 107–111. [CrossRef]
93.
Sandyk, R.; Pardeshi, R. The relationship between ECT nonresponsiveness and calcification of the pineal
gland in bipolar patients. Int. J. Neurosci. 1990,54, 301–306. [CrossRef]
Appl. Sci. 2020,10, 2885 10 of 10
94.
Friedland, R.P.; Luxenberg, J.S.; Koss, E.A. A quantitative study of intracranial calcification in dementia of
the Alzheimer type. Int. Psychogeriatr. 1990,2, 36–43. [CrossRef]
95.
Mahlberg, L.; Walther, S.; Kalus, P.; Bohner, G.; Haedel, S.; Reischies, F.M.; Kuhl, K.P.; Hellweg, R.; Kunz, D.
Pineal calcification in Alzheimer’s disease: An
in vivo
study using computed tomography. Neurobiol. Aging
2008,29, 203–209. [CrossRef]
96.
Tuntapakul, S.; Kitkhuandee, A.; Kanpittaya, J.; Johns, J.; Johns, N.P. Pineal calcification is associated with
pediatric primary brain tumor. Asia Pac. J. Clin. Oncol. 2016,12, e405–e410. [CrossRef] [PubMed]
97.
Kitkhuandee, A.; Sawanyawisuth, K.; Johns, N.P.; Kanpittaya, J.; Johns, J. Pineal calcification is associated
with symptomatic cerebral infarction. J. Stroke Cerebrovasc. Dis. 2014,23, 249–253. [CrossRef] [PubMed]
98.
Ozlece, H.K.; Akyuz, O.; Huseyinoglu, N.; Aydin, S.; Can, S.; Serim, V.A. Is there a correlation between the
pineal gland calcification and migraine? Eur. Rev. Med. Pharmacol. Sci. 2015,19, 3861–3864. [PubMed]
99.
Kunz, D.; Bes, F.; Schlattmann, P.; Herrmann, W.M. On pineal calcification and its relation to subjective sleep
perception: A hypothesis-driven pilot study. Psychiatry Res. 1998,82, 187–191. [CrossRef]
100.
Mori, R.; Kodaka, T.; Sano, T. Preliminary report on the correlation among pineal concretions, prostatic
calculi and age in human adult males. Anat. Sci. Int. 2003,78, 181–184. [CrossRef]
101.
Liebrich, L.S.; Schredl, M.; Findeisen, P.; Groden, C.; Bumb, J.M.; Nölte, I.S. Morphology and function:
MR pineal
volume and melatonin level in human saliva are correlated. J. Magn. Reson. Imaging
2014
,40,
966–971. [CrossRef]
102.
Tan, D.-X.; Manchester, L.C.; Reiter, R.J. CSF generation by pineal gland results in a robust melatonin circadian
rhythm in the third ventricle as a unique light/dark signal. Med. Hypotheses 2016,86, 3–9. [CrossRef]
103.
Reiter, R.J.; Tan, D.-X.; Kim, S.J.; Cruz, M.H.C. Delivery of pineal melatonin to the brain and SCN: Role of
canaliculi, cerebrospinal fluid, tanycytes and Virchow-Robin perivascular spaces. Brain Struct. Funct. 2014,
219, 1873–1887. [CrossRef]
104.
Zhou, J.-N.; Liu, R.-Y.; Kamphorst, W.; Hofman, M.A.; Swaab, D.F. Early neuropathological Alzheimer’s
changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J. Pineal Res.
2003,35, 125–130. [CrossRef]
105.
Michotte, Y.; Lowenthal, A.; Knaepen, L.; Colland, M.; Massart, D.L. A morphological and chemical study of
calcification of the pineal gland. J. Neurol. 1977,215, 209–219. [CrossRef]
106.
Bharti, V.K.; Srivastava, R.S. Effect of pineal proteins at different dose level on fluoride-induced changes
in plasma biochemicals and blood antioxidants enzymes in rats. Biol. Trace Elem. Res.
2011
,141, 275–282.
[CrossRef]
107.
Bharti, V.K.; Srivastava, R.S. Fluoride-induced oxidative stress in rat’s brain and its amelioration by buffalo
(Bubalus bubalis) pineal proteins and melatonin. Biol. Trace Elem. Res. 2009,130, 131–140. [CrossRef]
108. Chlubek, D. Fluoride and oxidative stress. Fluoride 2003,36, 217–228.
109.
Rzeuski, R.; Chlubek, D.; Machoy, Z. Interactions between fluoride and biological free radical reactions.
Fluoride 1998,31, 43–45.
110.
Chlubek, D.; Machoy, Z. Significance of the effect of fluorine dose on enzymes activity in
in vivo
and
in vitro studies. Bromat. Chem. Toksykol. 1989,22, 235–245.
©
2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).